Company: SXTPW
Filing Date: 2025-07-16
Form Type: 424B4
Source: 0001213900-25-064472
Chunk: 1

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-07-16
Form: 424B4
Chunk 1
---
 than 4.99% (or, at the election of the purchaser, 9.99%) of our outstanding common stock immediately
following the consummation of this offering. Each Pre-Funded Warrant will be exercisable for one share of common stock at an exercise
price of $0.001 per share. Each Pre-Funded Warrant is being issued together with the same Warrants described above being issued with each
share of common stock. The combined public offering price for each such Pre-Funded Warrant, together with accompanying the Warrants, is
$1.899, which is the combined public offering price per common share and accompanying Warrants less $0.001. Each Pre-Funded Warrant will
be exercisable upon issuance and may be exercised at any time until all of the Pre-Funded Warrants are exercised in full. The Pre-Funded
Warrants and accompanying Warrants are immediately separable and will be issued separately in this offering.

Pursuant to the registration statement related
to this prospectus, we are also registering the offer and sale of the shares of common stock issuable upon exercise of the Warrants and
the Pre-Funded Warrants and the placement agent warrants (the “Placement Agent Warrants”) issuable to H.C. Wainwright &
Co., LLC (the “placement agent”) as compensation in connection with the placement agent’s services in this offering,
and the shares of common stock issuable upon the exercise of the Placement Agent Warrants.

Our common stock is listed on The Nasdaq Capital
Market under the symbol “SXTP.” The last reported sale price of our common stock on The Nasdaq Capital Market on July 14,
2025 was $2.165 per share.

There is no established public trading market
for the Warrants or Pre-Funded Warrants. We do not intend to apply to list the Pre-Funded Warrants or the Warrants on any national securities
exchange or other nationally recognized trading system. Without an active trading market, the liquidity of the Pre-Funded Warrants and
the Warrants will be limited.

This offering will terminate on August 30, 2025,
unless we decide to terminate the offering (which we may do at any time in our discretion) prior to that date. We expect to have a single
closing for all the securities purchased in this offering. We will deliver all securities to be issued in connection with this offering
delivery versus payment/receipt versus payment upon receipt by us of investor funds